ebook img

Autoimmune hemolytic anemia (AIHA) - Swisstransfusion PDF

38 Pages·2012·5.45 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Autoimmune hemolytic anemia (AIHA) - Swisstransfusion

Autoimmune hemolytic anemia (AIHA) Sacha Zeerleder, MD PhD Internist – hematologist Department of Hematology Academic Medical Center Amsterdam Department of Immunopathology, Sanquin Research, Amsterdam [email protected] Autoimmune hemolytic anemia (AIHA) AIHA is characterized by an increased breakdown of red blood cells (RBC) due to autoantibodies (auto-Ab’s) with/without complement activation. Pathogenesis AIHA AIHA is characterized by an increased breakdown of red blood cells (RBC) due to autoantibodies (auto-Ab’s) with/without complement activation. RBC antigens Ineffective antigen presentation • Rh-related polypeptides • Immature DCs • Molecular mimicry • Decreased co-stimulatory help by T- • Oxidative changes in RBC antigen cells structure? AIHA Complement system Functional B/T cell abnormalities • Altered expression of CR1 • Polyclonal lymphocyte activation • Decreased experssion membran- • Alteration of cytokine profile boud complement regulators (CD59) • Dysregulation of T-Regs Diagnosis AIHA AIHA is characterized by an increased breakdown of red blood cells (RBC) due to autoantibodies (auto-Ab’s) with/without complement activation. Laboratory analyses: • Hemolysis (LDH , haptoglobine , hyperbilirubinemia) • Positive Coombs • (reticulocytosis) Specificity of autoantibodies: • Rhesus antigen (50% in AHIA with warm autoantibodies) • I/i antigen (AHIA cold antibodies) • P-antigen (paroxsysomal cold hemoglobinuria) But: biological activity of the autoantibody determines the clinical activity rather then than the specificity of the autoantibody AIHA: biological activity of autoantibodies Isotype autoantibody: determines complement activation and Fc gamma receptor binding Complement activation: • IgM: most efficient • IgG1, IgG3: efficient • IgG2, IgA: weak • IgG4: no complement activation Fc-gamma receptors • IgG1, IgG3 FcgRI (CD64) • IgG (low affinity) FcgRIIa AIHA: complement activation C1s C1r C1s C1r AIHA: complement activation C2 C4 C1s C1r C2a C4b AIHA: complement activation C3c C3 FI C3c C3b C3d C3b C3d AIHA: complement activation C5 C6 C7 C5b C8 C3b AIHA – destruction of autologous RBCs RBC-lysis Complement activation CR receptor depositie Fc-gamma receptor

Description:
Autoimmune hemolytic anemia (AIHA) Sacha Zeerleder, MD PhD Internist – hematologist Department of Hematology Academic Medical Center Amsterdam
See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.